Investor Relations

News Releases

Webcast
Apadaz Update Call
Friday, February 23, 2018 at 2:30 PM EST
Date Title
10/22/09
Summary ToggleKemPharm, Inc. Announces Initiation of Phase 1 Trial of KP106 for ADHD
09/16/09
Summary ToggleKemPharm, Inc. Expands Prodrug Pipeline with Candidate for Treatment of Pain and Closes Series B Financing